Показать сокращенную информацию

dc.contributor.authorGeretto, Marta
dc.contributor.authorPonassi, Marco
dc.contributor.authorCasale, Martina
dc.contributor.authorPulliero, Alessandra
dc.contributor.authorCafeo, Grazia
dc.contributor.authorMalagreca, Ferdinando
dc.contributor.authorAldo Profumo, Aldo
dc.contributor.authorBalza, Enrica
dc.contributor.authorBersimbaev, Rakhmetkazhi
dc.contributor.authorKohnke, Franz Heinrich
dc.contributor.authorRosano, Camillo
dc.contributor.authorIzzotti, Alberto
dc.date.accessioned2024-10-18T09:54:33Z
dc.date.available2024-10-18T09:54:33Z
dc.date.issued2018
dc.identifier.issn20452322
dc.identifier.otherDOI 10.1038/s41598-018-29314-9
dc.identifier.urihttp://rep.enu.kz/handle/enu/17978
dc.description.abstractmeso-(p-acetamidophenyl)-calix[4]pyrrole 3 was found to exhibit remarkable cytotoxicity towards A549 cancer cells. A comparative study including the isomer of 3meso-(m-acetamidophenyl)-calix[4]pyrrole 5, as well as molecules containing ‘fragments’ of these structures, demonstrated that both the calix[4]pyrrole and the acetamidophenyl units are essential for high cytotoxicity. Although calix[4]pyrroles and other anion-complexing ionophores have recently been reported to induce apoptosis by perturbing cellular chloride concentrations, in our study an alternative mechanism has emerged, as proven by the isolation of covalent DNA adducts revealed by the 32P postlabelling technique. Preliminary pharmacokinetic studies indicate that 3 is able to cross the Blood-Brain-Barrier, therefore being a potential drug that could kill primary and brain metastatic cancer cells simultaneously.ru
dc.language.isoenru
dc.publisherScientific Reportsru
dc.relation.ispartofseriesТом 8, Выпуск 11;Номер статьи 11075
dc.titleA novel calix[4]pyrrole derivative as a potential anticancer agent that forms genotoxic adducts with DNAru
dc.typeArticleru


Файлы в этом документе

Thumbnail

Данный элемент включен в следующие коллекции

Показать сокращенную информацию